BamSEC and AlphaSense Join Forces
Learn More

Revance Therapeutics Inc.

NASDAQ: RVNC    
Share price (1/8/25): $3.39    
Market cap (1/8/25): $356 million

Indentures Filter

EX-4.4
from 10-K 4 pages Description of Revance Therapeutics, Inc. Securities
12/34/56
EX-4.8
from S-3ASR 18 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Revance Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3ASR 20 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Revance Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3ASR 20 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Revance Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from 10-K 4 pages Description of Revance Therapeutics, Inc. Common Stock
12/34/56
EX-4.4
from 10-K 4 pages Description of Revance Therapeutics, Inc. Common Stock
12/34/56
EX-4.4
from 10-K 3 pages Description of Revance Therapeutics, Inc. Common Stock
12/34/56
EX-4.8
from S-3ASR 18 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Revance Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3ASR 20 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Revance Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3ASR 20 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Revance Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.5
from S-3ASR 55 pages Revance Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20 Debt Securities
12/34/56
EX-4.4
from 10-K 3 pages Description of Revance Therapeutics, Inc. Common Stock
12/34/56
EX-4.1
from 8-K 110 pages Revance Therapeutics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of February 14, 2020 1.75% Convertible Senior Notes Due 2027
12/34/56
EX-4.7
from S-3ASR 16 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of [•], 20 Revance Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3ASR 17 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of [•], 20 Revance Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.5
from S-3ASR 17 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of [•], 20 Revance Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3ASR 55 pages [Corporation], Issuer and [Trustee], Trustee Indenture Dated as of [•], 20 Debt Securities
12/34/56
EX-4.8
from S-3 22 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of [ ], 20 Revance Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3 24 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of [ ], 20 Revance Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3 24 pages Revance Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of [ ], 20 Revance Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56